(MEMPHIS, Tenn. – August 5, 2024) Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer...
Since the first immunotherapy drug to boost the body’s immune response against advanced lung cancer was introduced in the United...
BUFFALO, NY- August 5, 2024 – A new research paper was published in Oncotarget's Volume 15 on July 12, 2024,...
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in...
A new pathway that is used by cancer cells to infiltrate the brain has been discovered by a team of...
A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma...
io9, a software company developing an AI platform for precision oncology that enables the correct front-line targeted therapy at diagnosis,...
Scientists at St. Jude Children’s Research Hospital have created a panel that is able to provide a diagnosis for >90%...
An estimated 16% of people worldwide live with a significant disability that impacts their daily life. Of this population, only...
Fewer side effects, improved chances of healing: the goal of precision medicine is to provide patients with the most individualized...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine